Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy for Two Doses of Intracavernous Injection of Wharton Jelly Stem Cells for the Treatment of Diabetic Erectile Dysfunction

NCT03751735 is registered in ClinicalTrials.gov with Sophia Al-Adwan as lead sponsor.

NCT NCT03751735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03751735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy for Two Doses of Intracavernous Injection of Wharton Jelly Stem Cells for the Treatment of Diabetic Erectile Dysfunction
Lead sponsor
Sophia Al-Adwan
Phase
Phase 1/2
Overall status
Completed
Start date
January 27, 2017
Completion date
February 26, 2019
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction associated with type 2 diabetes mellitus